[{"NetIncomeLoss_1_Q2_USD":-83793000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-99000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"DepreciationAndAmortization_2_Q2_USD":4540000.0,"DepreciationAndAmortization_1_Q2_USD":2300000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":37135000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":19397000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":91806000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":92152000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"GainLossOnSaleOfPropertyPlantEquipment_2_Q2_USD":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-234000.0,"RestrictedCashCurrent_0_Q2_USD":194000.0,"PaymentsToAcquireShortTermInvestments_2_Q2_USD":158869000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":62000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":45388000.0,"AssetsCurrent_0_Q2_USD":392325000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":14460256.0,"IncomeTaxesPaidNet_2_Q2_USD":7000.0,"CommonStockSharesIssued_0_Q2_shares":84754000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":367998000.0,"Assets_0_Q2_USD":456791000.0,"ShareBasedCompensation_2_Q2_USD":26075000.0,"InterestPaidNet_2_Q2_USD":18000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":-250000.0,"Liabilities_0_Q2_USD":125253000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1618177000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":68475000.0,"ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments_2_Q2_USD":208515000.0,"FinanceLeasePrincipalPayments_2_Q2_USD":130000.0,"ProceedsFromStockPlans_2_Q2_USD":4348000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":135000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":225000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":16000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":16000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_2_Q2_USD":-851000.0,"IncreaseDecreaseInDeferredRevenue_2_Q2_USD":2188000.0,"CommonStockValue_0_Q2_USD":8000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0_Q2_USD":69526000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_2_Q2_USD":-5135000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_0_Q2_USD":298394000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":5339000.0,"RestrictedCash_0_Q2_USD":1400000.0,"RestrictedStockValueSharesIssuedNetOfTaxWithholdings_1_Q2_USD":13000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-162362000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-83892000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":4356000.0,"OtherAssetsNoncurrent_0_Q2_USD":689000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":123856000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":12182000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":11548000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":132534000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":20293665.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":2382000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1286709000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-1250000.0,"CommonStockSharesOutstanding_0_Q2_shares":84754000.0,"RestrictedCashNoncurrent_0_Q2_USD":1200000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":24065000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-162112000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-83777000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":1244000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":13807000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-127275000.0,"AccretionExpense_2_Q2_USD":43000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q2_USD":298472000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":-76548000.0,"AccountsPayableCurrent_0_Q2_USD":12301000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":125250000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":18751000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":-18000.0,"InterestReceivable_0_Q2_USD":700000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":1000000.0,"ProceedsFromPaymentsForOtherFinancingActivities_2_Q2_USD":-17000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":51029000.0,"NetIncomeLoss_2_Q2_USD":-162128000.0,"LiabilitiesCurrent_0_Q2_USD":88830000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":4258000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":22470000.0,"StockholdersEquity_0_Q2_USD":331538000.0,"IncreaseDecreaseInOtherCurrentLiabilities_2_Q2_USD":1522000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_0_Q2_USD":69541000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-2419000.0,"CommonStockSharesAuthorized_0_Q2_shares":500000000.0,"OperatingIncomeLoss_2_Q2_USD":-162247000.0,"OperatingIncomeLoss_1_Q2_USD":-84002000.0,"AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_0_Q2_USD":367935000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":40968000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":456791000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":15323000.0,"PreferredStockSharesAuthorized_0_Q2_shares":20000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":26075000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":13807000.0,"CapitalUnitsAuthorized_0_Q2_shares":520000000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":75094000.0,"OperatingExpenses_2_Q2_USD":169669000.0,"OperatingExpenses_1_Q2_USD":87872000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.77,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.91,"ProfitLoss_2_Q2_USD":-162128000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":1771000.0,"OtherLiabilitiesCurrent_0_Q2_USD":7367000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"ShortTermInvestments_0_Q2_USD":249524000.0,"Ticker":"ATRA","CIK":"1604464","name":"ATARA BIOTHERAPEUTICS, INC.","OfficialName":"Atara Biotherapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"734540687.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210809"}]